A Novel Frameshift Mutation in SLC2A1 Associated with a Mild form of Glucose Transporter Type 1-Related Movement Disorder

Yasser M. Awaad; Ian R. Berry; Hoda Y. Tomoum; Solaf M. Elsayed

doi:10.1055/s-0035-1556765

Journal of Pediatric Neurology, Table of Contents

Journal of Pediatric Neurology 2015; 13(02): 088-091
DOI: 10.1055/s-0035-1556765

Case Report

Georg Thieme Verlag KG Stuttgart · New York

A Novel Frameshift Mutation in SLC2A1 Associated with a Mild form of Glucose Transporter Type 1-Related Movement Disorder

Yasser M. Awaad

¹Department of Pediatric Neurology, National Neurosciences Institute, King Fahad Medical City, King Abdulaziz Bin Saud University, Riyadh, Saudi Arabia

,

Ian R. Berry

²Yorkshire Regional Genetics Service, DNA Laboratory, Ashley Wing, St James's University Hospital, United Kingdom

,

Hoda Y. Tomoum

³Department of Pediatrics, Ain Shams University, Cairo, Egypt

,

Solaf M. Elsayed

⁴Medical Genetics Center and Genetics Unit, Department of Pediatrics, Ain Shams University, Cairo, Egypt

› Author Affiliations

Abstract

The phenotypic spectrum of glucose transporter type 1 (GLUT1) deficiency syndrome is now known to be a continuum that includes the classic phenotype as well as atypical childhood absence epilepsy, myoclonic astatic epilepsy, and paroxysmal nonepileptic findings such as intermittent ataxia, choreoathetosis, dystonia, and alternating hemiplegia. We report the case of a mentally normal child with history of infantile seizures, which remitted but later developed nonepileptic movement disorder, responsive to carbohydrate intake, with a novel frameshift mutation (c.1344_1347delCTAC p.Y449fs) in the last exon of the GLUT1 gene. This case further broadens the phenotypic spectrum of GLUT1 deficiency syndrome. We provide evidence from this case and previous reports that mutations affecting the length and composition of the intracellular C-terminal domain of the GLUT1 protein have a variable and somewhat unpredictable range of pathological effects. These range from null phenotypes associated with C-terminal domain absence, to milder presentations associated with C-terminal domains comprising partially and (in this case study) completely abnormal amino acid sequences.

Keywords

GLUT1 - glucose transporter - SLC2A1

Full Text

References

References
1 De Vivo DC, Trifiletti RR, Jacobson RI, Ronen GM, Behmand RA, Harik SI. Defective glucose transport across the blood-brain barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N Engl J Med 1991; 325 (10) 703-709
2 Klepper J, Leiendecker B. GLUT1 deficiency syndrome—2007 update. Dev Med Child Neurol 2007; 49 (9) 707-716
3 Rotstein M, De Vivo DC. Childhood absence epilepsy as a manifestation of GLUT1 deficiency. Ann Neurol 2010; 67 (2) 272-273 , author reply 273
4 Leen WG, Klepper J, Verbeek MM , et al. Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder. Brain 2010; 133 (Pt 3): 655-670
5 Suls A, Dedeken P, Goffin K , et al. Paroxysmal exercise-induced dyskinesia and epilepsy is due to mutations in SLC2A1, encoding the glucose transporter GLUT1. Brain 2008; 131 (Pt 7): 1831-1844
6 Veggiotti P, Teutonico F, Alfei E , et al. Glucose transporter type 1 deficiency: ketogenic diet in three patients with atypical phenotype. Brain Dev 2010; 32 (5) 404-408
7 Rotstein M, Doran J, Yang H, Ullner PM, Engelstad K, De Vivo DC. Glut1 deficiency and alternating hemiplegia of childhood. Neurology 2009; 73 (23) 2042-2044
8 Mullen SA, Suls A, De Jonghe P, Berkovic SF, Scheffer IE. Absence epilepsies with widely variable onset are a key feature of familial GLUT1 deficiency. Neurology 2010; 75 (5) 432-440
9 De Vivo DC, Wang D. Glut1 deficiency: CSF glucose. How low is too low?. Rev Neurol (Paris) 2008; 164 (11) 877-880
10 Yang H, Wang D, Engelstad K , et al. Glut1 deficiency syndrome and erythrocyte glucose uptake assay. Ann Neurol 2011; 70 (6) 996-1005
11 Wilke CO. Transcriptional robustness complements nonsense-mediated decay in humans. PLoS Genet 2011; 7 (10) e1002296
12 Lange P, Gertsen E, Monden I, Klepper J, Keller K. Functional consequences of an in vivo mutation in exon 10 of the human GLUT1 gene. FEBS Lett 2003; 555 (2) 274-278
13 Wang D, Pascual JM, Yang H , et al. Glut-1 deficiency syndrome: clinical, genetic, and therapeutic aspects. Ann Neurol 2005; 57 (1) 111-118
14 Scheffer IE. GLUT1 deficiency: a glut of epilepsy phenotypes. Neurology 2012; 78 (8) 524-525
15 Afawi Z, Suls A, Ekstein D , et al. Mild adolescent/adult onset epilepsy and paroxysmal exercise-induced dyskinesia due to GLUT1 deficiency. Epilepsia 2010; 51 (12) 2466-2469
16 Alter AS, Engelstad K, Hinton VJ , et al. Long-term clinical course of glut1 deficiency syndrome. J Child Neurol 2015; 30 (2) 160-169
17 Friedman JR, Thiele EA, Wang D , et al. Atypical GLUT1 deficiency with prominent movement disorder responsive to ketogenic diet. Mov Disord 2006; 21 (2) 241-245
18 Oka Y, Asano T, Shibasaki Y , et al. C-terminal truncated glucose transporter is locked into an inward-facing form without transport activity. Nature 1990; 345 (6275) 550-553
19 Due AD, Qu ZC, Thomas JM, Buchs A, Powers AC, May JM. Role of the C-terminal tail of the GLUT1 glucose transporter in its expression and function in Xenopus laevis oocytes. Biochemistry 1995; 34 (16) 5462-5471
20 Muraoka A, Hashiramoto M, Clark AE , et al. Analysis of the structural features of the C-terminus of GLUT1 that are required for transport catalytic activity. Biochem J 1995; 311 (Pt 2): 699-704
21 Seidner G, Alvarez MG, Yeh JI , et al. GLUT-1 deficiency syndrome caused by haploinsufficiency of the blood-brain barrier hexose carrier. Nat Genet 1998; 18 (2) 188-191